Cancer Pharmacology and Drug Discovery- Tenure Track Faculty (Assistant/Associate)

Posting Summary Rutgers Cancer Institute invites applications for faculty positions in cancer research for tenure track and non-tenure track positions. New tenure track faculty are expected to establish or support an innovative, independent and collaborative research program addressing important, fundamental questions in the area of cancer biology. Interdisciplinary and translational approaches are encouraged that establish collaborations with consortium faculty. Candidates with a demonstrated ability to secure peer reviewed funding are preferred. Faculty will have the exciting opportunity to be involved in teaching activities for medical students and residents as well as targeted lectures in their area of expertise. We invite applications for an Assistant or Associate Professor level, tenure track faculty position with a research focus in cancer pharmacology, including drug discovery and development, the biology of key molecular targets of cancer, and mechanisms of action and resistance of cancer therapies. We are especially interested in individuals with strong background in translation of basic science to patient care or drug discovery applying DNA -encoded library screening, molecular glue, PROTAC and other innovative small molecule drug discovery technologies, or therapeutic antibody engineering and development. Additionally, we welcome candidates engaged in preclinical and/or clinical therapeutics research that originates from, or is directly informed by, the laboratory science of the programs' current/future effort. Our Cancer Pharmacology Research Program offers an exciting, collaborative research environment with attractive packages available for qualified candidates. New faculty are expected to establish or support an innovative, independent, and collaborative research program addressing important, fundamental questions in the areas of Cancer Pharmacology and Drug Discovery. Rutgers Cancer Institute is an NCI -designated, comprehensive and consortium cancer center that includes faculty members from across Rutgers University (including Rutgers Robert Wood Medical School, Rutgers Biomedical and Health Sciences) and Princeton University. We are a leader in basic, clinical, prevention, and public health science, offering world-class quality cancer care providing the most advanced medicines and treatment options for patients in our health system network across the state. Visit our website at For questions on this position or to learn more about our available positions, please contact the Rutgers Cancer Institute Faculty Recruitment Office at View email address on click.appcast.io. Posting Summary Rutgers Cancer Institute invites applications for faculty positions in cancer research for tenure track and non-tenure track positions. New tenure track faculty are expected to establish or support an innovative, independent and collaborative research program addressing important, fundamental questions in the area of cancer biology. Interdisciplinary and translational approaches are encouraged that establish collaborations with consortium faculty. Candidates with a demonstrated ability to secure peer reviewed funding are preferred. Faculty will have the exciting opportunity to be involved in teaching activities for medical students and residents as well as targeted lectures in their area of expertise. We invite applications for an Assistant or Associate Professor level, tenure track faculty position with a research focus in cancer pharmacology, including drug discovery and development, the biology of key molecular targets of cancer, and mechanisms of action and resistance of cancer therapies. We are especially interested in individuals with strong background in translation of basic science to patient care or drug discovery applying DNA -encoded library screening, molecular glue, PROTAC and other innovative small molecule drug discovery technologies, or therapeutic antibody engineering and development. Additionally, we welcome candidates engaged in preclinical and/or clinical therapeutics research that originates from, or is directly informed by, the laboratory science of the programs' current/future effort. Our Cancer Pharmacology Research Program offers an exciting, collaborative research environment with attractive packages available for qualified candidates. New faculty are expected to establish or support an innovative, independent, and collaborative research program addressing important, fundamental questions in the areas of Cancer Pharmacology and Drug Discovery. Rutgers Cancer Institute is an NCI -designated, comprehensive and consortium cancer center that includes faculty members from across Rutgers University (including Rutgers Robert Wood Medical School, Rutgers Biomedical and Health Sciences) and Princeton University. We are a leader in basic, clinical, prevention, and public health science, offering world-class quality cancer care providing the most advanced medicines and treatment options for patients in our health system network across the state. Visit our website at For questions on this position or to learn more about our available positions, please contact the Rutgers Cancer Institute Faculty Recruitment Office at View email address on click.appcast.io. Overview RBHS Overview: New Jersey's premier academic health center, Rutgers Biomedical and Health Sciences (RBHS) takes an integrated approach to educating students, providing clinical care, and conducting research, all with the goal of improving human health. Aligned with Rutgers University-New Brunswick and collaborating university wide, RBHS includes eight schools, a behavioral health network, and five centers and institutes that focus on cancer treatment and research, neuroscience, advanced biotechnology and medicine, environmental and occupational health, and health care policy and aging research. Our renowned faculty are teachers, health researchers and providers, and scientists with unparalleled experience who advance medical innovation and provide patient care informed by the latest research findings. We offer an outstanding education and training in medicine, dentistry, pharmacy, public health, nursing, biomedical research, and the full spectrum of allied health careers. An important mission of RBHS is to promote the careers of faculty, staff, and learners. Through this community of healers, scientists, and scholars, Rutgers is equipped as never before to transform lives. Rutgers Robert Wood Johnson Medical School As one of the nation's comprehensive medical schools, Rutgers Robert Wood Johnson Medical School (RWJMS) is dedicated to pursuing excellence in education, research, healthcare delivery, and the promotion of community health. In cooperation with Robert Wood Johnson University Hospital, the medical school's principal affiliate, they comprise New Jersey's premier academic medical center. In addition, RWJMS has 34 other hospital affiliates and ambulatory care sites throughout the region. RWJMS encompasses 20 basic science and clinical departments and hosts centers and institutes, described below. The medical school maintains undergraduate, graduate, and postgraduate educational programs for more than 1,500 students on its campuses in New Brunswick and Piscataway. It provides continuing education courses for healthcare professionals and community education programs. Previously an academic unit of the University of Medicine and Dentistry of New Jersey, RWJMS became part of Rutgers, The State University of New Jersey, as part of the New Jersey Medical and Health Sciences Education Restructuring Act, on July 1, 2013. Rutgers Cancer Institute: The Rutgers Cancer Institute is the only NCI -designated Comprehensive Cancer Center in New Jersey, and a leader in laboratory, clinical prevention and public health science. Rutgers Cancer Institute offers world-class quality cancer care providing the most advanced medicines and treatment options for patients in its New Brunswick facility as well as at its network of hospitals across the state through the partnership with the Robert Wood Johnson Barnabas Health System and University Hospital in Newark. The new Jack & Sheryl Morris Cancer Center is a state-of-the-art, freestanding cancer hospital featuring outpatient and inpatient capacity coupled with research laboratories, retail space and ancillary services devoted to patient wellness and is a first of its kind in New Jersey. It includes the wide-ranging advanced oncology care services offered by Rutgers Cancer Institute and RWJBarnabas Health, all under one roof - greatly enhancing the patient experience and providing further ease of access. Learn more about this incredible facility at #J-18808-Ljbffr Rutgers University